Trajectory, risk factors, and impact of abdominal pain during the first year after pediatric IBD diagnosis: Results from the ImproveCareNow Network
Murphy L, Gashi K, Kawamura J, Zhou C, Lynch D, Suskind D, Palermo T. Trajectory, risk factors, and impact of abdominal pain during the first year after pediatric IBD diagnosis: Results from the ImproveCareNow Network. J Pediatr Gastroenterol Nutr 69 2019;(S1): S95-96
Reduction in corticosteroid usage among pediatric patients with inflammatory bowel disease in a large learning health system
Kandavel P, Adler J, Meister S. Reduction in corticosteroid usage among pediatric patients with inflammatory bowel disease in a large learning health system. J Pediatr Gastroenterol Nutr 69 2019;(S1): S232-233
Insurance status but not race determines sustained remission in pediatric IBD
Doan S, Jofriet A, Scott O, Riswan A, Venkateswaran S, Somineni H, Niklinska-Schirtz B, Talmadge C, Fritzen C, Dinser M, Dykes D, Gold B, Sauer C, Kugathasan S, Schoen B. Insurance status but not race determines sustained remission in pediatric IBD. J Pediatr Gastroenterol Nutr 69 2019;(S1): S80-81
Anemia prevalence in pediatrics IBD: Still persisted after 1 year
Malik P, Kim M, Puopolo G, Thompson J, Tomer G. Anemia prevalence in pediatrics IBD: Still persisted after 1 year. J Pediatr Gastroenterol Nutr 69 2019;(S1): S244-245
Hospitalizations in children with inflammatory bowel disease
Alper A, Algara M, Phatak U, Pashankar D. Hospitalizations in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 69 2019;(S1): S64-65